Zymeworks Inc. (ZYME) Financials

ZYME Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 478.2 billion 314.6 billion
Dec. 31, 2025 346.5 million 78.0 million
Sept. 30, 2025 397.3 million 77.2 million
June 30, 2025 408.4 million 73.9 million

ZYME Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -45.7 billion 6.9 billion
Dec. 31, 2025 -10.6 million -3.4 million
Sept. 30, 2025 -31.8 million 6.9 million
June 30, 2025 11.2 million 5.9 million

ZYME Net Income

No data available :(

ZYME Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 364.7 billion 13.8 billion 13.8 million
Dec. 31, 2025 228.8 million - 14.8 million
Sept. 30, 2025 251.9 million - 15.5 million
June 30, 2025 281.4 million - 18.7 million

ZYME Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 74.7 million
Dec. 31, 2025 75.3 million
Sept. 30, 2025 75.8 million
June 30, 2025 77.4 million

ZYME Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 216000 2.4 billion 15.1 billion -
Dec. 31, 2025 569895 31.2 million 13.7 million -
Sept. 30, 2025 410000 35.6 million 14.1 million -
June 30, 2025 884000 34.4 million 14.9 million -

ZYME Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.4 million 2.8 million
Dec. 31, 2025 2.5 million 1.7 million
Sept. 30, 2025 27.6 million -
June 30, 2025 48.7 million 3.2 million

ZYME Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ZYME

Price: $22.86

52 week price:
11.51
29.75

Earnings Per Share: -1.37 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 105946

Ebitda: -15.5 million

Market Capitalization: 1.9 billion

Links: